Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Glabellar Botulinum Toxin Injections for the Treatment of Geriatric Depression

NCT03833063 is registered in ClinicalTrials.gov with Helse Stavanger HF as lead sponsor.

NCT NCT03833063
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03833063 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Glabellar Botulinum Toxin Injections for the Treatment of Geriatric Depression
Lead sponsor
Helse Stavanger HF
Phase
Phase 1
Overall status
Withdrawn
Start date
May 1, 2019
Completion date
March 31, 2020
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

major depressive disorder, major depressive episode, treatment resistant depression